The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Papadakis, K. A.
Right arrow Articles by Targan, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Papadakis, K. A.
Right arrow Articles by Targan, S. R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
The Journal of Immunology, 2004, 172: 7002-7007.
Copyright © 2004 by The American Association of Immunologists

TL1A Synergizes with IL-12 and IL-18 to Enhance IFN-{gamma} Production in Human T Cells and NK Cells1

Konstantinos A. Papadakis2,*, John L. Prehn2,*, Carol Landers*, Qiwei Han*, Xia Luo{dagger}, Stephanie C. Cha*, Ping Wei{dagger} and Stephan R. Targan3,*

* Cedars-Sinai Inflammatory Bowel Disease Center, Los Angeles, CA 90048; and {dagger} Human Genome Sciences, Rockville, MD 20850

TL1A, a recently described TNF-like cytokine that interacts with DR3, costimulates T cells and augments anti-CD3 plus anti-CD28 IFN-{gamma} production. In the current study we show that TL1A or an agonistic anti-DR3 mAb synergize with IL-12/IL-18 to augment IFN-{gamma} production in human peripheral blood T cells and NK cells. TL1A also enhanced IFN-{gamma} production by IL-12/IL-18 stimulated CD56+ T cells. When expressed as fold change, the synergistic effect of TL1A on cytokine-induced IFN-{gamma} production was more pronounced on CD4+ and CD8+ T cells than on CD56+ T cells or NK cells. Intracellular cytokine staining showed that TL1A significantly enhanced both the percentage and the mean fluorescence intensity of IFN-{gamma}-producing T cells in response to IL-12/IL-18. The combination of IL-12 and IL-18 markedly up-regulated DR3 expression in NK cells, whereas it had minimal effect in T cells. Our data suggest that TL1A/DR3 pathway plays an important role in the augmentation of cytokine-induced IFN-{gamma} production in T cells and that DR3 expression is differentially regulated by IL-12/IL-18 in T cells and NK cells.




This article has been cited by other articles:


Home page
J. Immunol.Home page
J. Zhang, X. Wang, H. Fahmi, S. Wojcik, J. Fikes, Y. Yu, J. Wu, and H. Luo
Role of TL1A in the Pathogenesis of Rheumatoid Arthritis
J. Immunol., October 15, 2009; 183(8): 5350 - 5357.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Tian, P. H. Liang, and L.-Y. Li
Inhibition of endothelial progenitor cell differentiation by VEGI
Blood, May 21, 2009; 113(21): 5352 - 5360.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Sattler, U. Wagner, M. Rossol, J. Sieper, P. Wu, A. Krause, W. A. Schmidt, S. Radmer, S. Kohler, C. Romagnani, et al.
Cytokine-induced human IFN-{gamma}-secreting effector-memory Th cells in chronic autoimmune inflammation
Blood, February 26, 2009; 113(9): 1948 - 1956.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
B. P. Pappu, A. Borodovsky, T. S. Zheng, X. Yang, P. Wu, X. Dong, S. Weng, B. Browning, M. L. Scott, L. Ma, et al.
TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease
J. Exp. Med., May 12, 2008; 205(5): 1049 - 1062.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
L. Fang, B. Adkins, V. Deyev, and E. R. Podack
Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation
J. Exp. Med., May 12, 2008; 205(5): 1037 - 1048.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
O. Cohavy and S. R. Targan
CD56 Marks an Effector T Cell Subset in the Human Intestine
J. Immunol., May 1, 2007; 178(9): 5524 - 5532.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. L. Prehn, L. S. Thomas, C. J. Landers, Q. T. Yu, K. S. Michelsen, and S. R. Targan
The T Cell Costimulator TL1A Is Induced by Fc{gamma}R Signaling in Human Monocytes and Dendritic Cells
J. Immunol., April 1, 2007; 178(7): 4033 - 4038.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Saruta, Q. T. Yu, A. Avanesyan, P. R. Fleshner, S. R. Targan, and K. A. Papadakis
Phenotype and Effector Function of CC Chemokine Receptor 9-Expressing Lymphocytes in Small Intestinal Crohn's Disease
J. Immunol., March 1, 2007; 178(5): 3293 - 3300.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Bamias, M. Mishina, M. Nyce, W. G. Ross, G. Kollias, J. Rivera-Nieves, T. T. Pizarro, and F. Cominelli
From the Cover: Role of TL1A and its receptor DR3 in two models of chronic murine ileitis
PNAS, May 30, 2006; 103(22): 8441 - 8446.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. A. Young and M. G. Tovey
TL1A: A mediator of gut inflammation
PNAS, May 30, 2006; 103(22): 8303 - 8304.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W. Hou, D. Medynski, S. Wu, X. Lin, and L.-Y. Li
VEGI-192, a New Isoform of TNFSF15, Specifically Eliminates Tumor Vascular Endothelial Cells and Suppresses Tumor Growth
Clin. Cancer Res., August 1, 2005; 11(15): 5595 - 5602.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. A. Papadakis, D. Zhu, J. L. Prehn, C. Landers, A. Avanesyan, G. Lafkas, and S. R. Targan
Dominant Role for TL1A/DR3 Pathway in IL-12 plus IL-18-Induced IFN-{gamma} Production by Peripheral Blood and Mucosal CCR9+ T Lymphocytes
J. Immunol., April 15, 2005; 174(8): 4985 - 4990.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.